Shortage of Fluoxetine (Medreich) 10 mg capsule

1 Feb 2024

Policy

Fluoxetine (Medreich ®) for the treatment of major depressive disorders and obsessive-compulsive disorder is now listed on the Pharmaceutical Benefits Scheme (PBS) for the current supply shortage under Section 19A.

For more information on Fluoxetine (Medreich ®), please contact the PBS directly.

More news & views

20 February 2025

College commitment to Raise the Age

The College is continuing to advocate in support of the Raise the Age (RTA) campaign.

20 February 2025

Planned review of treatment guidelines for trans and gender diverse children and adolescents

The College welcomes the Australian Federal government announcement regarding a comprehensive review...

17 January 2025

Updates to clinical guidelines and College publications in 2024

During 2024, various College position statements and clinical guidelines were created or updated.